K-PHOS #2 Rx
Generic Name and Formulations:
Potassium acid phosphate 305mg, sodium acid phosphate 700mg; equiv. to potassium 2.3mEq and sodium 5.8mEq; tabs.
- Survival Rates With Parenteral Prostanoids in Pulmonary Arterial Hypertension
- Current Smokers With Severe Asthma Distinguished by Sputum Proteomics
- Children With Status Asthmaticus Do Not Benefit From Magnesium Sulfate
Indications for K-PHOS #2:
1 tab 4 times a day with a full glass of water. If urine very alkaline, 1 tab every 2 hours; max 8 tabs daily.
Renal or adrenal insufficiency. Severe hepatic disease. Infected phosphate stones. Hyperphosphatemia. Hyperkalemia (Original).
Electrolyte restrictions. Cardiac disease. Hypertension. Edema. Monitor serum electrolytes and for GI obstruction. Discontinue if laxation persists after dosage reduction. Hypoparathyroidism. Osteomalacia. Pancreatitis. Dehydration. Toxemia of pregnancy. Pregnancy (Cat.C). Nursing mothers.
Antagonized by antacids. Hyperkalemia with ACE inhibitors, triamterene, spironolactone, amiloride, potassium supplements. Toxicity with digitalis. Hypernatremia with methyldopa, guanethidine, other antihypertensives, corticotropins, mineralocorticoids.
Small bowel lesions, laxation, headache, dizziness, hyperacidity, nausea, weakness, confusion, paresthesias, seizures, arrhythmias, shortness of breath, edema.